tykhr
sign in
free sign up
Zenas BioPharma, Inc. Common Stock
Biotechnology
Healthcare
ZBIO
41.80 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
18.95
52 week high
25.68
high
19.58
52 week low
0.00
low
18.29
growth
-0.21 %
previous Close
18.95
P/E ratio
market cap
461 M
div yield
0
usd
Mar 2025
qoq
revenue
10.00 M
100.00 %
net incoming
-33.57 M
36.18 %
eps
0.00 %
36.44 %
eps surprise
22.33 %
net profit margin
-335.73 %
716.00 %
operating incoming
-47.33 M
14.91 %
net change in cash
-123.28 M
-205.94 %
cash on hand
197 M
-38.53 %
cost of revenue
0.00 %
top